Inhibition of Murine Systemic Leishmaniasis by Acetyl Salicylic Acid Via Nitric Oxide Immunomodulation

Inhibition of Murine Systemic Leishmaniasis by Acetyl Salicylic Acid Via Nitric Oxide Immunomodulation

Show other versions (1)

Background: The purpose of this study was to evaluate antileishmanial effects of ASA via NO pathway in Leishmania major infected Balb/c mice. Moreover, toxicity and pathological consequences of ASA administration were investigated.Methods: Balb/c mice were infected with L. major and ASA was inoculat...

Full description

Bibliographic Details
Main Authors:	M Assmar, M Farahmand, M Jalalian, H Nahrevanian, AR Esmaeili Rastaghi, M Sayyah
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2012-06-01
Series:	Iranian Journal of Parasitology
Subjects:	ASA Balb/c Leishmania Major Immunotherapy
Online Access:	http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/20954.pdf&manuscript_id=20954

Similar Items

Inhibition of Murine Systemic Leishmaniasis by Acetyl Salicylic Acid via Nitric Oxide Immunomodulation
by: H Nahrevanian, et al.
Published: (2012-06-01)

Treatment of Cutaneous Leishmaniasis in Murine Model by Hydro Alcoholic Essence of Artemisia sieberi
by: A Doroodgar, et al.
Published: (2008-12-01)

Pathogenicity Variations of Susceptibility and Resistance to Leishmania major MRHO/IR/75/ER Strain in BALB/c and C57BL/6 mice
by: Marzieh Amini, et al.
Published: (2008-12-01)

Therapeutic Effect of Scrophularia striata Ethanolic Extract against Localized Cutaneous Leishmaniasis Caused by Leishmania major (MRHO/IR/75/ER)
by: Malihe ZAHIRI, et al.
Published: (2016-10-01)

Pathogenicity Variations of Susceptibility and Resistance to Leishmania major MRHO/IR/75/ER Strain in BALB/c and C57BL/6 mice
by: Marzieh Amini, et al.
Published: (2008-12-01)

Immunological Effects of Leishmania major Secretory and Excre¬tory Products on Cutaneous Leishmaniasis in BALB/c Mice
by: A Mahmoodzadeh, et al.
Published: (2007-05-01)

Therapeutic effect of acupuncture in BALB/c model of cutaneous leishmaniasis
by: Mahshid Shakibapour, et al.
Published: (2015-01-01)

Therapeutic Effect of Sodium Selenite and Zinc Sulphate as Supplementary with Meglumine Antimoniate( Glucantime®) Against Cutaneous Leishmaniasis In BALB/C Mice
by: M Mohebali, et al.
Published: (2010-09-01)

Therapeutic Effect of Sodium Selenite and Zinc Sulphate as Sup-plementary with Meglumine Antimoniate( Glucantime®) Against Cutaneous Leishmaniasis In BALB/C Mice
by: F Zamani Sorkhroodi, et al.
Published: (2010-09-01)

The Effect(s) of Matricaria chamomilla on Leishmania major Ulcers in Balb/c Mice
by: AR Dashtpeima, et al.
Published: (2015-05-01)

Biochemical association between essential trace elements and susceptibility to Leishmania major in BALB/c and C57BL/6 mice
by: Marzyeh Amini, et al.

The Multiple Forms of Leishmania Major in BALB/C Mice Lung in Iran
by: M Jafari, et al.
Published: (2012-06-01)

The Multiple Forms of Leishmania major in BALB/C Mice Lung in Iran
by: Sh Shirbazou, et al.
Published: (2012-06-01)

Topical Effectiveness of Different Concentrations of Nanosilver Solution on Leishmania Major Lesions in Mice (Balb/c)
by: Mohammad Ali Nilforoushzadeh, et al.
Published: (2011-12-01)

The Role of Liposomal CpG ODN on the Course of L. major Infection in BALB/C Mice
by: H Hejazi, et al.
Published: (2010-02-01)

The Role of Liposomal CpG ODN on the Course of L. major Infection in BALB/C Mice
by: H Hejazi, et al.
Published: (2010-03-01)

Topical effectiveness of different concentrations of nanosilver solution on Leishmania major lesions in Balb/c mice
by: Mohammad Ali Nilforoushzadeh , Leila Shirani-Bidabadi , Azadeh Zolfaghari-Baghbaderani , Reza Jafari , Motahar Heidari-Beni , Amir Hossein Siadat & Mehdi Ghahraman-Tabrizi
Published: (2012-12-01)

Evaluation of Alum-Naltrexone Adjuvant Activity, on Efficacy of Anti-Leishmania Immunization with Autoclaved Leishmania major (MRHO/IR/75/ER) Antigens in BALB/C Mice
by: Habib Mohammadzadeh Hajipirloo, et al.
Published: (2014-09-01)

Route of Infection Affects Pathogenicity of Leishmania major in BALB/c Mice
by: Ehsan Sarreshteh, et al.
Published: (2017-01-01)

Immunization against Leishmania major infection in BALB/c mice using a subunit-based DNA vaccine derived from TSA, LmSTI1, KMP11, and LACK predominant antigens
by: Vahid Jajarmi, et al.
Published: (2019-12-01)

Induction of Oxidative Stress in Skin and Lung of Infected BALB/C Mice with Iranian Strain of Leishmania major (MRHO/IR/75/ER)
by: Mahvash Jafari, et al.
Published: (2014-03-01)

Evaluation of Immune Response against Leishmaniasis in BALB/c Mice Immunized with Cationic DOTAP/DOPE/CHOL Liposomes Containing Soluble Leishmania major Antigens
by: Mansure HOJATIZADE, et al.
Published: (2019-03-01)

Nematicidal Activity of Acetyl Salicylic Acid against Root-Knot Nematode on Tomato Plants.
by: Raddy H. M., et al.
Published: (2020-11-01)

Evaluación de formulaciones de ketoconazol para uso tópico en leishmaniasis cutánea por Leishmania (Viannia)
by: Angélica M. Vera, et al.
Published: (2018-09-01)

In Vivo Efficacy of Gum Obtained Pistacia Atlantica in Experimental Treatment of Cutaneous Leishmaniasis
by: M Taran, et al.
Published: (2010-03-01)

In Vivo Efficacy of Gum Obtained Pistacia Atlantica in Experimental Treatment of Cutaneous Leishmaniasis
by: M Taran, et al.
Published: (2010-03-01)

Study of the in vitro and in vivo antileishmanial activities of nimodipine in susceptible BALB/c mice
by: Reza Azadi, et al.
Published: (2020-01-01)

Immunomodulation From Moderate Exercise Promotes Control of Experimental Cutaneous Leishmaniasis
by: Rodrigo Terra, et al.
Published: (2019-05-01)

Avaliação de interação entre neutrófilos e leishmania braziliensis
by: Falcão, Sarah de Athayde Couto
Published: (2013)

Protective Effect of Vitamin D3 and Gp63 Conjugated with Tetanus Toxoid on Outcome of Cutaneous Leishmaniasis Lesions in Balb/C Mice
by: S Soudi, et al.
Published: (2006-01-01)

Expression of Cytokine Genes in Leishmania major-Infected BALB/c Mice Treated with Mesenchymal Stem Cells
by: Sahar Hamoon Navard, et al.
Published: (2020-01-01)

Comparison of Parasite Burden Using Real-Time Polymerase Chain Reaction Assay and Limiting Dilution Assay in Leishmania major Infected Mouse
by: Somayeh GHOTLOO, et al.
Published: (2015-12-01)

Behavior of Leishmania major metacyclic promastigotes during the course of infection and immune response development in resistant versus susceptible hosts Comportamento de promastigoteas metacíclicos de Leishmania major durante o curso da infecção e da resposta imune em hospedeiros resistentes versus suscetíveis
by: Regina Coeli Cunha Dórea, et al.
Published: (2003-11-01)

Isolated lingual leishmaniasis
by: Habibzadeh F, et al.
Published: (2005-01-01)

Treatment Outcome of the Drug-resistant Zoonotic Cutaneous Leishmaniasis by Glucantime
by: Simindokht Soleimanifard, et al.
Published: (2017-01-01)

Antileishmanial activity of a new chloroquine analog in an animal model of Leishmania panamensis infection
by: Lizzi Herrera, et al.
Published: (2020-12-01)

Histological and immunological differences between zoonotic cutaneous leishmaniasis due to Leishmania major and sporadic cutaneous leishmaniasis due to Leishmania infantum
by: Boussoffara Thouraya, et al.
Published: (2019-01-01)

Geographical Distribution of Leishmania Species of Human Cutaneous Leishmaniasis in Fars Province, Southern Iran
by: M Akhoundi, et al.
Published: (2013-03-01)

Geographical Distribution of Leishmania Species of Human Cutaneous Leishmaniasis in Fars Province, Southern Iran
by: M Akhoundi, et al.
Published: (2013-03-01)

Leishmaniasis in central and southern Tunisia: current geographical distribution of zymodemes
by: Haouas N., et al.
Published: (2007-09-01)

Cannot write session to /tmp/vufind_sessions/sess_ov9m1tnli91q8lsljqqkie6upo